Figure 3.
![PFS of low-risk vs intermediate-/high-risk MGUS patients irrespective of concomitant RD. PFS of patients with or without rheumatic impairment in years from MGUS diagnosis stratified by the risk group profile. The risk group profile is based on currently applied transformation risk scores that include the amount of M-protein, Ig type, and free light chain ratio. The number of patients at risk, the number of events (eg, 1329/33), and HRs [95% CIs] are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/5/6/10.1182_bloodadvances.2020003193/2/advancesadv2020003193f3.png?Expires=1735817678&Signature=CF~KHcDklSH0SAsKrl90agU0U5T4-MR77Cc7whMaiXG9jYrRugspJFLjZ94T6~SzSBqCTutqys73UMrxBp9As4SqL10WerVpb32g1q8xqcuLbWbD7-UWF62juCLP1~CE3Rteyuj9pXBrogNygfTOZJUWWc5ktwOvYQHC95bQWvt3fdXIJuXotzEW4~WCZjZtFvHOZ56w9Poh-V2Z5VA-Wosi5iRyW-upkDSoB8YKbA9tIy-3J~ty9lx1eN67mXjyEv7ErhA7cA6q6nHgl-6fcVu1MUiJq9eGC2cJx7o~8pqB-D6yLfK1NscxMYE20RqQyHWm0MqY~CWz5Opza6kgBQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PFS of low-risk vs intermediate-/high-risk MGUS patients irrespective of concomitant RD. PFS of patients with or without rheumatic impairment in years from MGUS diagnosis stratified by the risk group profile. The risk group profile is based on currently applied transformation risk scores that include the amount of M-protein, Ig type, and free light chain ratio. The number of patients at risk, the number of events (eg, 1329/33), and HRs [95% CIs] are shown.